Dimensional Fund Advisors
SPRY icon

Dimensional Fund Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Dimensional Fund Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-115,523
Closed -$925K – 3279
2026
Q2 		$925K Sell
115,523
-56,816
-33% -$489K ﹤0.01% 2880
2026
Q1 		$1.38M Sell
172,339
-3,783
-2% -$36.3K ﹤0.01% 2779
2025
Q4 		$2.05M Sell
176,122
-2,026
-1% -$19.7K ﹤0.01% 2734
2025
Q3 		$1.79M Sell
178,148
-2,344
-1% -$33.6K ﹤0.01% 2787
2025
Q2 		$3.15M Sell
180,492
-7,153
-4% -$103K ﹤0.01% 2639
2025
Q1 		$2.36M Sell
187,645
-8,813
-4% -$106K ﹤0.01% 2687
2024
Q4 		$2.07M Buy
196,458
+4,010
+2% +$56.2K ﹤0.01% 2777
2024
Q3 		$2.79M Hold
192,448
– – ﹤0.01% 2701
2024
Q2 		$1.64M Sell
192,448
-82,841
-30% -$735K ﹤0.01% 2808
2024
Q1 		$2.81M Sell
275,289
-49,437
-15% -$369K ﹤0.01% 2708
2023
Q4 		$1.78M Sell
324,726
-49,012
-13% -$215K ﹤0.01% 2810
2023
Q3 		$1.41M Sell
373,738
-19,912
-5% -$131K ﹤0.01% 2851
2023
Q2 		$2.64M Buy
393,650
+59,391
+18% +$396K ﹤0.01% 2710
2023
Q1 		$2.18M Buy
+334,259
New +$2.57M ﹤0.01% 2728
2022
Q3 		$1.75M Buy
330,734
+266,613
+416% +$1.31M ﹤0.01% 2750
2022
Q2 		$272K Buy
+64,121
New +$224K ﹤0.01% 3199

Other funds holding SPRY

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Tyro Capital Management
Tyro Capital Management Miami, Florida $564M AUM 72.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $52.3B AUM 19.7% 1-Year Est. Return
Creek Drive Management Group
Creek Drive Management Group San Francisco, California $368M AUM 23.05% 1-Year Est. Return

Dimensional Fund Advisors's SPRY Position: Q3 2026 in Review

Dimensional Fund Advisors sold out of ARS Pharmaceuticals (SPRY) in Q3 2026, closing a stake of 115,523 shares — an estimated $925K sold.

Dimensional Fund Advisors first reported a position in SPRY in Q2 2022 and held it in 16 quarters. The position peaked at $3.15M in Q2 2025. 133 funds tracked by Wall St. Rank hold SPRY as of Q3 2026.

  • Dimensional Fund Advisors reported no remaining ARS Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 115,523 ARS Pharmaceuticals shares in Q3 2026, an estimated $925K.
  • Dimensional Fund Advisors first reported a position in ARS Pharmaceuticals in Q2 2022 and held it in 16 quarters.
  • Dimensional Fund Advisors's ARS Pharmaceuticals position peaked at $3.15M in Q2 2025.
  • 133 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.